Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

Invitation to Elekta’s Capital Markets Day 2023

Elekta

STOCKHOLM – Elekta (EKTA-B.ST) invites investors, analysts and financial media to join Elekta’s Capital Markets Day (CMD) on June 20, 2023.

The purpose of the CMD is to give an update of Elekta’s strategy to provide the best cancer care for patients worldwide. Topics to be covered are innovations, including software, improving our customers’ clinical workflows through services and partnerships, as well as driving adoption of the latest technology across the globe. Speakers at the event will include Gustaf Salford, President and CEO as well as other leaders of Elekta.
 
The CMD will be broadcast live online and we also welcome institutional investors and financial analysts to attend in person at Elekta’s office in Crawley, UK. The webcast will start at 09:45 BST and end at 12:15 BST, including a Q&A session. For those attending in person, there will then be lunch together with members of the Executive Management team followed by the opportunity to get a closer look at Elekta’s product portfolio. A recording of the CMD will be published on Elekta’s website after the event.
 
To attend (online or in person) and for more information, please register through the following link no later than June 4, 2023: https://events.elekta.com/elekta-s-capital-markets-day
 
# # #
 
For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CEST (Central European Summer Time)
 
About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.

Attachments


Press Release Invitation To CMD 2023 EN

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.